IL7 and neoplasm: In a complex double-transgenic mouse model using LCMV infection as a vaccine against a spontaneous SV40-driven tumor mouse model, Pellegrini et al. observed that short term IL-7 therapy potently enhanced vaccine-mediated immunity, though it was inefficient in promoting antitumor immune responses in the absence of vaccination.